期刊
MOLECULES
卷 27, 期 19, 页码 -出版社
MDPI
DOI: 10.3390/molecules27196574
关键词
Trypanosoma brucei brucei; MMV Pathogen Box; antitrypanosomal; MMV675968 (2; 4-diaminoquinazoline); in silico; structure-activity relationship; DHFR inhibitor; time-kill kinetic; DNA fragmentation
资金
- Grand Challenges Africa program [GCA/DD/rnd3/006]
- African Academy of Sciences (AAS)
- Bill & Melinda Gates Foundation (BMGF)
- Medicines for Malaria Venture (MMV)
- Drug Discovery and Development Centre of University of Cape Town (H3D)
Novel drugs are urgently needed for the treatment of human African trypanosomiasis (HAT). In this study, a small library of antitrypanosomal analogs was screened, and two potent analogs were identified, showing much higher activity than the parent hit. These two analogs have potential as starting points for further drug development.
New drugs are urgently needed for the treatment of human African trypanosomiasis (HAT). In line with our quest for novel inhibitors of trypanosomes, a small library of analogs of the antitrypanosomal hit (MMV675968) available at MMV as solid materials was screened for antitrypanosomal activity. In silico exploration of two potent antitrypanosomal structural analogs (7-MMV1578647 and 10-MMV1578445) as inhibitors of dihydrofolate reductase (DHFR) was achieved, together with elucidation of other antitrypanosomal modes of action. In addition, they were assessed in vitro for tentative inhibition of DHFR in a crude trypanosome extract. Their ADMET properties were also predicted using dedicated software. Overall, the two diaminoquinazoline analogs displayed approximately 40-fold and 60-fold more potency and selectivity in vitro than the parent hit, respectively (MMV1578445 (10): IC50 = 0.045 mu M, SI = 1737; MMV1578467 (7): IC50 = 0.06 mu M; SI = 412). Analogs 7 and 10 were also strong binders of the DHFR enzyme in silico, in all their accessible protonation states, and interacted with key DHFR ligand recognition residues Val32, Asp54, and Ile160. They also exhibited significant activity against trypanosome protein isolate. MMV1578445 (10) portrayed fast and irreversible trypanosome growth arrest between 4-72 h at IC99. Analogs 7 and 10 induced in vitro ferric iron reduction and DNA fragmentation or apoptosis induction, respectively. The two potent analogs endowed with predicted suitable physicochemical and ADMET properties are good candidates for further deciphering their potential as starting points for new drug development for HAT.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据